Publication | Closed Access

The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways

Tumor BiologyMedicineLiver PhysiologyPharmacologyCancer Cell BiologyPathologyLiver CancerOncologyHepatocellular CarcinomaCancer Research